Health-RELATED quality of life from the MM-003 trial of pomalidomide plus LOW-Dose dexamethasone VERSUS HIGH-DOSE dexamethasone in relapsed and/or refractory multiple myeloma

Kevin W. Song*, Meletios A. Dimopoulos, Katja C. Weisel, Philippe Moreau, Antonio Palumbo, Andrew Belch, Stephen Schey, Pieter Sonneveld, Lars Sternas, Xin Yu, Ramesh Amatya, Mara S. Monzini, Mohamed Zaki, Christian Jacques, Jesus San Miguel

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    23 Citations (Scopus)
    237 Downloads (Pure)
    Original languageEnglish
    Pages (from-to)63-67
    Number of pages5
    JournalHaematologica
    Volume100
    Issue number2
    DOIs
    Publication statusPublished - Feb 2015

    Keywords

    • Multiple myeloma
    • Pomalidomide
    • Quality of life

    Cite this